It has been added to the cart.

It has been added to the comparison table.

LabAssay (TM) AST (GOT)

for Cellbiology
Manufacturer :
FUJIFILM Wako Pure Chemical Corporation
Storage Condition :
Keep at 2-10 degrees C.
GHS :
  • Structural Formula
  • Label
  • Packing
SDS
Comparison
Product Number
Package Size
Price
Availability
Certificate of Analysis
Purchase
Distributor
299-97601
Barcode No
4548995106780
100Tests
List Price
549.00 USD

In stock in Japan

Document

SDS
Product Specification Sheet
Package Insert
Spectral Data
Certificate of Analysis
Calibration Certificate
Analytical Charts

Kit component

For 100 tests

Substrate-Enzyme Solution 12 mL / 1 bottle
α-KG Solution 11 mL / 1 bottle
AST Standard 2 bottles
Buffer 6 mL / 1 bottle
Stop Solution 12 mL / 1 bottle

Product Overview

Aspartate aminotransferase (AST) is an aminotransferase enzyme that catalyzes the conversion of L-aspartate and α-ketoglutarate into glutamate and oxaloacetate. AST is highly abundant in the liver, myocardium, and skeletal muscle and is released into the bloodstream due to increased cell permeability or cell death. Therefore, it serves as a marker for organ damage, including liver injury. AST is also useful indicators of liver fibrosis caused by conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD).
LabAssay™ AST (GOT) is a kit used for the determination of AST in blood (serum, plasma). With the use of a microplate, this kit provides a quick and convenient method for measuring AST in samples.

[Note] LabAssay™ series are reagents for research purposes. It cannot be used for diagnostic purposes.

Kit Performance

Analysis sample Mouse Serum/Plasma
Rat Serum/Plasma
Dog Serum/Plasma
Cat Serum/Plasma
Calibration curve range 0-405 U/L
Sample volume 7 μL
Measurement duration Approx. 40 min
Wavelength Primary wavelength 340 nm
Reference wavelength 405 nm

Example of Calibration Curve

Example of Calibration Curve

Assay Principle

When a sample is mixed with Substrate-Enzyme Solution and α-KG Solution, glutamate and oxaloacetate are formed from L-aspartate and α-ketoglutarate in a reaction catalyzed by AST in the sample. The oxaloacetate thus produced is converted to malate by malate dehydrogenase (MDH). At the same time, NADH is oxidized to NAD, and the absorbance at 340 nm decreases. Finally, the reaction is stopped using a reaction Stop Solution, and the absorbance is measured to determine the AST activity value in the sample.

Figure 1 Principle of the AST (GOT) assay
Figure 1 Principle of the AST (GOT) assay

Data

Dilution Linearity Test

Serum and plasma (EDTA) from mouse, rat, dog and cat were serially diluted twofold with saline and measured in duplicate to assess linearity.

Mouse serum/plasma (EDTA)
Rat serum/plasma (EDTA)
Dog serum/plasma (EDTA)
Cat serum/plasma (EDTA)

[Result]
All measurement results showed good linearity within the measurement range.

Spike and Recovery Test

Standard solutions at three concentrations were added to serum/plasma (EDTA) from mouse, rat, dog and cat. Next, spike recovery tests were conducted, with each measurement performed in duplicate.

Mouse sample (BALB/c)

Spiked amount
(U/L)
Measurement value
(U/L)
Recovery volume
(U/L)
Recovery rate
(%)
Serum - <2.31 - -
67.1 63.7 63.7 94.9
98.7 90.0 90.0 91.2
129 124 124 96.1
Average 94.1
Plasma
(EDTA)
- <2.31 - -
67.1 58.6 58.6 87.3
98.7 93.7 93.7 94.9
129 142 142 110
Average 97.4

Rat sample (S.D. rat)

Spiked amount
(U/L)
Measurement value
(U/L)
Recovery volume
(U/L)
Recovery rate
(%)
Serum - 34.8 - -
16.1 52.6 17.8 111
31.8 64.2 29.4 92.5
91.8 135 100 109
Average 104
Plasma
(EDTA)
- 32.4 - -
15.5 47.4 15.0 96.8
30.7 61.7 29.3 95.4
88.8 128 95.6 108
Average 100

Dog sample (Beagle)

Spiked amount
(U/L)
Measurement value
(U/L)
Recovery volume
(U/L)
Recovery rate
(%)
Serum - 24.0 - -
14.2 38.4 14.4 101
28.2 56.7 32.7 116
68.5 96.3 72.3 106
Average 108
Plasma
(EDTA)
- 44.4 - -
17.0 60.2 15.8 92.9
33.7 77.2 32.8 97.3
81.8 138 93.6 114
Average 101

Cat sample (Japanese Cat)

Spiked amount
(U/L)
Measurement value
(U/L)
Recovery volume
(U/L)
Recovery rate
(%)
Serum - 24.3 - -
14.3 38.4 14.1 98.6
28.3 51.3 27.0 95.4
68.8 86.7 62.4 90.7
Average 94.9
Plasma
(EDTA)
- 38.0 - -
17.3 52.1 14.1 81.5
34.2 69.4 31.4 91.8
67.1 103 65.0 96.9
Average 90.1

[Result]
Good recovery rates were confirmed.

FAQ

About sample

Which anticoagulants can I use?
Anticoagulants such as heparin, citrate and EDTA do not significantly influence the assay when used in normal amounts.
What should I do with samples that exceed the measurable range?
Dilute specimen with saline and repeat the assay if the measured value exceeds the measurable range, and multiply the result by the dilution factor.
Is there any influence from substances that interfere with measurement (hemolysis, chyle, ascorbic acid, bilirubin, etc.)?
Please treat the measured values of hemolyzed samples as reference values. Chyle, ascorbic acid, and bilirubin have almost no effect on the measured values. We have confirmed that there is no influence at the following concentrations.

Effects of interfering substances

Hemolysis No influence up to 25 mg/dL
Chyle No influence up to 500 FTU
Ascorbic acid No influence up to 50 mg/dL
Bilirubin-F No influence up to 50 mg/dL
Bilirubin-C No influence up to 10 mg/dL

About kit usage

What instruments, and equipment are required for the assay using this kit?
The instruments and equipment required for the use of this kit are listed below.
  • 96-well microplate (transparent type)
  • Micropipette
  • Pipette
  • Microtube
  • Incubator maintained at 37 ℃
  • Plate mixer
  • Microplate reader with 340 nm/405 nm wavelength filter
What is the amount of purified water to be added to the standard product?
Find and check “Reconstitution of standard” on this product page. As the amount of purified water to be added varies by lot, be sure to check it for every lot.

Overview / Applications

Property

Manufacturer Information

Alias

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.